Poolbeg Pharma PLC
Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; … Read more
Market Cap & Net Worth: Poolbeg Pharma PLC (POLBF)
Poolbeg Pharma PLC (PINK:POLBF) has a market capitalization of $83.20 Million ($83.20 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #20307 globally and #7381 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Poolbeg Pharma PLC's stock price $0.12 by its total outstanding shares 705103778 (705.10 Million).
Poolbeg Pharma PLC Market Cap History: 2022 to 2025
Poolbeg Pharma PLC's market capitalization history from 2022 to 2025. Data shows growth from $51.47 Million to $83.20 Million (5.66% CAGR).
Poolbeg Pharma PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Poolbeg Pharma PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of POLBF by Market Capitalization
Companies near Poolbeg Pharma PLC in the global market cap rankings as of March 18, 2026.
Key companies related to Poolbeg Pharma PLC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Poolbeg Pharma PLC Historical Marketcap From 2022 to 2025
Between 2022 and today, Poolbeg Pharma PLC's market cap moved from $51.47 Million to $ 83.20 Million, with a yearly change of 5.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $83.20 Million | 0.00% |
| 2024 | $83.20 Million | +2.61% |
| 2023 | $81.09 Million | +57.53% |
| 2022 | $51.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Poolbeg Pharma PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $83.20 Million USD |
| MoneyControl | $83.20 Million USD |
| MarketWatch | $83.20 Million USD |
| marketcap.company | $83.20 Million USD |
| Reuters | $83.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.